Agent exhibits activity in leukemias, MDSApril 4, 2018AnemiaLeukemia, Myelodysplasia, TransplantationAMLMyelodysplastic SyndromeCML
FDA approves nilotinib for kids with CMLMarch 23, 2018Leukemia, Myelodysplasia, TransplantationPediatricsPharmacyCML
Ponatinib efficacy maintained despite dose reductionsMarch 23, 2018Leukemia, Myelodysplasia, TransplantationCML
Drug could improve treatment of CML, team saysMarch 7, 2018Leukemia, Myelodysplasia, TransplantationCML
CHMP backs bosutinib for newly diagnosed CMLFebruary 28, 2018Leukemia, Myelodysplasia, TransplantationPharmacyCML
Expanded UCB product can stand aloneFebruary 27, 2018AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersTransplantationAMLALLMyelodysplastic Syndrome
Survival differences among AYAs with blood cancersJanuary 11, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAMLALLHodgkin LymphomaCMLNon-Hodgkin Lymphoma
Marine animals aid development of cytotoxicity assayJanuary 11, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAMLCMLNon-Hodgkin LymphomaAggressive Lymphomas
Nilotinib label updated with info on discontinuationDecember 23, 2017Leukemia, Myelodysplasia, TransplantationPharmacyCML
FDA expands approved use of bosutinib in CMLDecember 20, 2017Leukemia, Myelodysplasia, TransplantationPharmacyCML
Company launches digital PCR test for monitoring CMLDecember 7, 2017Leukemia, Myelodysplasia, TransplantationCML
Companies launch generic busulfan in USDecember 6, 2017Leukemia, Myelodysplasia, TransplantationPharmacyCML
Nilotinib approved to treat kids with CML in EUNovember 21, 2017Leukemia, Myelodysplasia, TransplantationPediatricsPharmacyCML
Dasatinib approved to treat kids with CMLNovember 11, 2017Leukemia, Myelodysplasia, TransplantationPediatricsPharmacyCML
Natural selection opportunities tied to cancer ratesOctober 13, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaAMLALLHodgkin LymphomaCML